Uncategorized

Pfizer Halts Development of Weight-Loss Pill – WSJ

Posted on Author Tim Hodges Comments Off on Pfizer Halts Development of Weight-Loss Pill – WSJ
  1. Pfizer Halts Development of Weight-Loss Pill  WSJ
  2. Pfizer scraps daily weight loss pill after liver injury in one patient  CNBC
  3. Pfizer Stock: Company Halts Obesity-Drug Development. What It Means for Eli Lilly, Novo Nordisk.  Barron’s
  4. Pfizer Provides Update on Oral GLP-1 Receptor Agonist Danuglipron  Business Wire
  5. Pfizer Abandons Obesity Pill After Liver Injury in Setback  Bloomberg.com